陳翊庭:港交所放寬上市條件以提升對內地新興科技企業吸引力
今年以來內地企業赴港上市成為熱潮,而港交所(00388.HK)上月初發布特專科技公司上市新規以來,有三間公司成功在港上市。港交所行政總裁陳翊庭向《央視》表示,港交所一直在簡化審核流程並且放寬上市條件,就是為了不斷提升香港資本市場對內地新興科技企業的吸引力。
陳翊庭認為,一些創新的行業為全球投資者一個非常好的投資的題材,投資者對正在申請在香港上市的公司都展現出非常濃厚的興趣。
中國證監會相關負責人則稱,會堅定推動資本市場高水準對外開放,支持科技企業充分運用境內外市場與資源。隨著中國資本市場雙向開放的深入推進,A股上市公司赴港上市有助於建構「境內產業鏈+境外資本鏈」模式,推動優質企業深度參與全球競爭。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.